Description

Ladostigil Tartrate is a synthetic compound of significant interest in pharmaceutical research and development. This compound matters for its potential neuroprotective and cognitive-enhancing properties, positioning it as a key intermediate or active pharmaceutical ingredient (API) in advanced therapeutic studies. It is primarily needed by pharmaceutical manufacturers, biotechnology firms, and academic research institutions focused on central nervous system (CNS) disorders, neurodegenerative diseases, and innovative drug discovery programs.

Application

• Pharmaceutical Intermediate: Serves as a critical building block in the synthesis of novel drug candidates targeting neurological pathways.
• Active Pharmaceutical Ingredient (API) Research: Used in preclinical and clinical research for the development of treatments for Alzheimer's disease and other dementias.
• Neuroprotective Agent Studies: Investigated in research models for its potential to protect neurons from degeneration and oxidative stress.
• Cognitive Enhancer Development: A key compound in studies aiming to develop therapeutics for cognitive impairment and memory loss.
• Monoamine Oxidase (MAO) and Cholinesterase Inhibitor Research: Utilized in pharmacological studies due to its dual inhibitory action on MAO and acetylcholinesterase enzymes.
• Reference Standard: Employed as a high-purity analytical standard in quality control laboratories for method development and validation.

Basic Information

Product Name	Ladostigil Tartrate
CAS No.	209394-46-7
Molecular Formula	C23H29N3O8
Molecular Weight	475.49 g/mol
Synonyms	(R)-N-Propargyl-1-aminoindan hemitartrate; TV-3326; Ladostigil hemitartrate; (R)-N-(2-Propynyl)-2,3-dihydro-1H-inden-1-amine (2R,3R)-2,3-dihydroxysuccinate (1:0.5); (R)-(-)-N-Propargyl-1-aminoindan (L)-(+)-tartrate; UNII-9I1VH5N71F
EINECS	Contact for details

Quality Control

Our Ladostigil Tartrate is manufactured under strict quality management systems to ensure high purity and batch-to-batch consistency, suitable for research and development applications. Each batch is accompanied by a comprehensive Certificate of Analysis (COA) detailing identity, purity, and impurity profiles. We adhere to relevant Good Manufacturing Practice (GMP) guidelines for pharmaceutical intermediates, and specifications can be aligned with client requirements for advanced research use.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated place at a controlled room temperature (typically 15-25°C). This material is hygroscopic (moisture-sensitive) and light-sensitive; therefore, containers must be kept tightly sealed and stored in a dark place to maintain stability and purity.

Specification

Item	Specification
Appearance	White to off-white powder
Identification (IR)	Conforms to reference spectrum
Identification (HPLC)	Retention time corresponds to reference standard
Assay (HPLC)	≥ 98.0%
Related Substances (HPLC)	Total impurities ≤ 2.0%
Single Unknown Impurity	≤ 0.5%
Water Content (KF)	≤ 1.0%
Residue on Ignition	≤ 0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.